Envíos recientes

Mostrando ítems 1066-1070 de 13715

Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial

2022- Muñoz-Rivas, N.; Aibar, J.; Gabara-Xancó, C.; Trueba-Vicente, Á.; Urbelz-Pérez, A.; [et al.]
Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors-Health-EpiGEICAM Study

2022- Lope, V.; Guerrero-Zotano, A.; Ruiz-Moreno, E.; Bermejo, B.; Antolín Novoa, Silvia; [et al.]
IgA Vasculitis: Influence of CD40, BLK and BANK1 Gene Polymorphisms

2022- Batista Liz, J.C.; Genre, F.; Pulito-Cueto, V.; Remuzgo-Martínez, S.; Prieto-Peña, D.; [et al.]
Guideline adherence in febrile children below 3 months visiting European Emergency Departments: an observational multicenter study

2022- Tan, C.D.; van der Walle, E.E.P.L.; Vermont, C.L.; von Both, U.; Carrol, E.D.; [et al.]
Pituitary tumor centers of excellence for Cushing's disease

2022- Couselo, M.; Frara, S.; Giustina, A.; Casanueva Freijo, Felipe